Hepatitis Delta Virus Testing, Prevalence, and Liver-Related Outcomes Among US Veterans With Chronic Hepatitis B
Among a national cohort of US Veterans with CHB, low rates of HDV testing were observed. This is concerning given that patients with concurrent HDV infection had >3 times and >5 times greater risks of cirrhosis and hepatic decompensation, respectively, compared to CHB patients without HDV, highlighting the importance of timely HDV diagnosis and treatment.
Authors
- Joseph K. Lim (ORCID: https://orcid.org/0000-0003-1126-8128)
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- Ramsey Cheung (ORCID: https://orcid.org/0000-0002-0211-7013)
- Binu V. John (ORCID: https://orcid.org/0000-0002-2002-9682)
- Janice H. Jou (ORCID: https://orcid.org/0000-0003-3005-2883)
- Zeyuan Yang (ORCID: https://orcid.org/0000-0001-5067-7560)
Institutions
- University of Miami (US)
- VA Palo Alto Health Care System (US)
- Yale Cancer Center (US)
- Portland VA Medical Center (US)
- Yale University (US)
- Palo Alto Veterans Institute for Research (US)
- Oregon Health and Science University Hospital (US)
- Miami VA Healthcare System (US)
- Stanford University (US)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1016/j.gastha.2024.10.015
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Pfizer
- Gilead Sciences
- Novo Nordisk